Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biocryst Pharma Inc (BCRX)

Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market

EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:BCRX),(NASDAQ:VERU),(NASDAQ:CMRX),(NASDAQ:SIGA) EQNX::TICKER_END

BCRX : 8.11 (-0.49%)
NNVC : 1.5700 (-0.63%)
VERU : 0.7798 (-2.67%)
CMRX : 0.8898 (+1.69%)
SIGA : 8.43 (-1.17%)
BioCryst Pharmaceuticals (BCRX) Q2 2024 Earnings Call Transcript

BCRX earnings call for the period ending June 30, 2024.

BCRX : 8.11 (-0.49%)
BioCryst: Q2 Earnings Snapshot

BioCryst: Q2 Earnings Snapshot

BCRX : 8.11 (-0.49%)
Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday

A better-than-expected first quarter and a goal of profitability and positive cash flow by the end of 2025 brought on a bit of a rally.

BCRX : 8.11 (-0.49%)
BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Monday, 5/6/2024

Stocks that traded heavily or had substantial price changes on Monday: BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall

THS : 41.94 (+0.19%)
IART : 17.40 (-0.40%)
FRPT : 142.19 (+0.67%)
BCRX : 8.11 (-0.49%)
NSSC : 39.58 (-2.20%)
BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript

BCRX earnings call for the period ending March 31, 2024.

BCRX : 8.11 (-0.49%)
BioCryst: Q1 Earnings Snapshot

BioCryst: Q1 Earnings Snapshot

BCRX : 8.11 (-0.49%)
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript

BCRX earnings call for the period ending December 31, 2023.

BCRX : 8.11 (-0.49%)
BioCryst: Q4 Earnings Snapshot

BioCryst: Q4 Earnings Snapshot

BCRX : 8.11 (-0.49%)
BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript

BCRX earnings call for the period ending September 30, 2023.

BCRX : 8.11 (-0.49%)

Barchart Exclusives

Snag This Biotech Stock Before November, Here's Why
With Viking Therapeutics making a splash in the weight-loss drug arena, one analyst is encouraging investors to snap up the stock before a November catalyst. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar